Jump to Main Content
- White, Reuben; Pulford, Emily; Elliot, David J.; Thurgood, Lauren A.; Klebe, Sonja
- Journal of proteomics 2019 v.192 pp. 374-382
- adenocarcinoma; asbestos; biomarkers; biopsy; early diagnosis; mass spectrometry; mesothelioma; patients; prognosis; proteins; proteome; vascular endothelial growth factors
- ... Malignant pleural mesothelioma (MPM) is a devastating malignancy with a prognosis of <12 months. Even with bans on the use of asbestos in most Western countries, the incidence is still increasing due to the long latency periods between exposure and development of the disease. Diagnosis is often delayed due to invasive biopsies and lack of distinguishable markers. Patients frequently present with p ...